Abstract
Anti-cannabinoid type 1 receptor (CB1) polyclonal antibodies are widely used to detect the presence of CB1 in a variety of brain cells and their organelles, including neuronal mitochondria. Surprisingly, we found that anti-CB1 sera, in parallel with CB1, also recognize the mitochondrial protein stomatin-like protein 2. In addition, we show that the previously reported effect of synthetic cannabinoid WIN 55,212-2 on mitochondrial complex III respiration is not detectable in purified mitochondrial preparations. Thus, our study indicates that a direct relationship between endocannabinoid signaling and mitochondrial functions in the cerebral cortex seems unlikely, and that caution should be taken interpreting findings obtained using anti-CB1 antibodies. We found that anti-CB1 sera, in parallel to CB1, also recognize the mitochondrial protein stomatin-like protein 2. In addition, we show that the previously reported effect of synthetic cannabinoid WIN 55,212-2 on mitochondrial complex III respiration is not detectable in purified mitochondrial preparations. Thus, our study indicates that a direct relationship between endocannabinoid signaling and mitochondrial functions in the cerebral cortex seems unlikely and that caution should be taken interpreting findings obtained using anti-CB1 antibodies. © 2013 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
Author supplied keywords
Cite
CITATION STYLE
Morozov, Y. M., Dominguez, M. H., Varela, L., Shanabrough, M., Koch, M., Horvath, T. L., & Rakic, P. (2013). Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria. European Journal of Neuroscience, 38(3), 2341–2348. https://doi.org/10.1111/ejn.12237
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.